Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 9/20 | 0.52 |
| ▸ | SCN5A | Q14524 | 6/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.46 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | FABP1 | P07148 | 1/20 | 0.38 |
| ▸ | FABP4 | P15090 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1246468 | 0.94 | SCN9A (0.55) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL1245362 | 0.93 | SCN9A (0.57) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL1246481 | 0.90 | SCN9A (0.54) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL1245178 | 0.90 | SCN9A (0.55) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL1246308 | 0.89 | SCN9A (0.55) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL1247366 | 0.88 | LPAR1 (0.49) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL1246466 | 0.88 | SCN9A (0.50) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL1245337 | 0.88 | SCN9A (0.54) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL3702336 | 0.87 | LPAR1 (0.60) | SCN9ASCN5ALPAR1LPAR2LPAR3 | |
| SCHEMBL1246952 | 0.87 | SCN9A (0.52) | SCN9ASCN5ALPAR1LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2462128-A2 | COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | Amira Pharmaceuticals, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| WO-2011017350-A2 | COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | AMIRA PHARMACEUTICALS, INC. (US) | 2011-02-10 | — | — | WO | claimed |